Live tape
Top 8, mentions 7d9,857TSLA2,037 mentions▲ +0.05GOOGL1,585 mentions▲ +0.04NVDA1,207 mentions▲ +0.07CRWV1,197 mentions▲ +0.03SPCX1,070 mentions▲ +0.07QQQ1,042 mentions▲ +0.04META874 mentions▲ +0.05NBIS845 mentions▲ +0.05

Equity · Healthcare

SNSE

NGM

Sensei Biotherapeutics Inc

Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for SNSE to draw a line in its place.

Track this symbol on TradingView TradingView chart

SNSE insider trades

SEC Form 4

SNSE has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 1 June 2026.

Date Insider Type Shares Value
01 Jun 2026 Cambrian BioPharma Inc 10% Owner Sell 25,000 $501K
01 Jun 2026 Peyer James 10% Owner Sell 25,000 $501K
09 Dec 2025 Cambrian BioPharma Inc Sell 6,612 $55K
09 Dec 2025 Peyer James Sell 3,507 $28K
08 Dec 2025 Peyer James Sell 3,105 $27K
05 Dec 2025 Cambrian BioPharma Inc Sell 16,295 $187K
05 Dec 2025 Peyer James Sell 16,295 $187K
04 Dec 2025 Cambrian BioPharma Inc Sell 5,000 $45K
04 Dec 2025 Peyer James Sell 5,000 $45K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
09 Dec 2025 Cambrian BioPharma Inc Option exercise 395 $3K
09 Dec 2025 Peyer James Option exercise 395 $3K

SNSE earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 −$131.45 —
31 Dec 2025 FY 2025 −$16.72 —
30 Sep 2025 Q3 2025 −$3.62 —
30 Jun 2025 Q2 2025 −$3.91 —
31 Mar 2025 Q1 2025 −$5.45 —
31 Dec 2024 FY 2024 −$24.01 —
30 Sep 2024 Q3 2024 −$5.77 —
30 Jun 2024 Q2 2024 −$5.69 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

SNSE institutional holders

SEC Form 13F SEC EDGAR

5 of the 45 institutional funds we track reported a SNSE position for the quarter ended 30 Jun 2026 — a combined $64.2M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Baker Bros. Advisors New position 1,286,411 $32.2M
Balyasny Asset Management Added +6,331.3% shares 1,042,198 $26.1M
Marshall Wace Added +214.2% shares 206,508 $5.2M
Renaissance Technologies Trimmed −36.3% shares 20,416 $510K
Citadel Advisors New position 12,296 $307K
Millennium Management Exited

Sources

  1. TradingViewthe price chart widget, drawn by TradingView from their own data
  2. SEC EDGARSEC EDGAR 13F filings